S

Sarcoma: adjuvant chemotherapy, systematic review and IPD meta-analysis

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual participant data

SELPHI

SELPHI: An HIV Self-testing Public Health Intervention

SHIELD

A phase II double-blind, placebo controlled, randomised, single centre study to assess the safety, tolerability and acceptability of dextrin-2-sulphate (DS) gel in sexually active female subjects and their male sexual partners at low risk of HIV infection

SHINE

A randomised trial of therapy shortening for minimal tuberculosis with new WHO-recommended doses/fixed-dose-combination drugs in African and Indian HIV+ and HIV- children

SimpliciTB

Evaluating the efficacy, safety and tolerability of a novel and potentially shorter drug regimen (BPaMZ) for patients with drug-sensitive (DS) and drug-resistant (MDR-) pulmonary tuberculosis

SMAART

Severe Malaria - A Research and Trials consortium

SMART

A large, simple trial comparing two strategies for management of anti-retroviral therapy

SMILE

Strategy for Maintenance of HIV suppression with once daily integrase inhibitor +darunavir/ritonavir in children

SNAP

Which standard of care antibiotic intervention is the most effective?

SORCE

A multi-centre phase III double-blind placebo-controlled study designed to examine the efficacy and tolerability of sorafenib (Nexavar) in patients with resected (total or partial) primary renal cell carcinoma (RCC) at high or intermediate risk of relapse

SPARTAC

Short Pulse Anti-Retroviral Therapy At sero-Conversion

ST02

A randomised, controlled trial of pre- and post-operative chemotherapy in patients with operable gastric and lower oesophageal cancer

ST03

A randomised phase II/III trial of perioperative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma and a feasibility study evaluating lapatinib in HER-2 positive oesophagogastric adenocarcinomas and (in selected centres) MRI and PET/CT sub-studies

STAMPEDE

Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy

STAND

Shorter Treatment for Advancing Novel Drugs

START

Strategic Timing of AntiRetroviral Treatment

STOP-HCV-1

Stratified Treatment Optimisation for HCV-1

STOPCAP M0, bisphosphonates, systematic review and aggregate data meta-analysis

Addition of bisphosphonates to standard of care in men with localised, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STOPCAP M0, docetaxel, systematic review and aggregate data meta-analysis

Addition of docetaxel to standard of care in men with localised hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STOPCAP M1 Programme

Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer

STOPCAP M1, abiraterone, systematic review and aggregate data meta-analysis

Addition of abiraterone to standard of care in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STOPCAP M1, aggregate data network meta-analysis

What is the optimal systemic treatment of men with metastatic, hormone-sensitive prostate cancer? a systematic review and network meta-analyses of aggregate data

STOPCAP M1, bisphosphonates, systematic review and aggregate data meta-analysis

Addition of bisphosphonates to standard of care in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STOPCAP M1, docetaxel, systematic review and aggregate data meta-analysis

Addition of docetaxel to standard of care in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STOPCAP M1, prostate RT, systematic review and aggregate data meta-analysis

Addition of prostate radiotherapy to ADT in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

STREAM Stage 1

The evaluation of a standardised treatment regimen of anti-tuberculosis drugs for patients with MDR-TB

STREAM Stage 2

The Evaluation of a Standardised Treatment Regimen of Anti-Tuberculosis Drugs for Patients with MDR-TB

STRIVE

Strategies and Treatments for Respiratory Infections & Viral Emergencies

Study C

A randomised international multi-centre trial for the evaluation of a four-drug fixed dose combined tablet daily in the initial phase (2 months) of chemotherapy followed by a two-drug fixed dose combined tablet three times a week in the continuation phase (4 months) for the treatment of pulmonary tuberculosis.

SURE

A randomised trial of 6 months intensified anti-tuberculosis and 2 months anti-inflammatory treatment for HIV-infected and HIV-uninfected African and Asian children with tuberculous meningitis

SWET

Softened Water Eczema Trial

STAMPEDE2

Studying Treatments in patients receiving androgen deprivation therapy (ADT) and androgen receptor signalling inhibitors (ARSI) for Metastatic Prostate Cancer: Evaluation of Drug and radiation Efficacy: A 2nd multi-arm multi-stage randomised controlled trial (STAMPEDE2).

SNIP-AFRICA

Severe neonatal infection adaptive platform trials in Africa